Login / Signup

Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis.

Garick D HillJoshua R KovachDavid E SaudekAnoop K SinghKarla WehrheimMichele A Frommelt
Published in: Prenatal diagnosis (2018)
Digoxin should not be first-line therapy for fetal tachycardia, particularly in the presence of hydrops fetalis. Flecainide should be the first-line therapy of choice in atrioventricular reentrant tachycardia. Further study may identify further sub-populations responding differently.
Keyphrases
  • catheter ablation
  • atrial fibrillation
  • replacement therapy